Home LiteratureArticle Details
PMID: 19336371 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants.

Pediatrics ·Vol. 123 ·No. 4 ·2009-04-00 ·Pages 1124-31

Laughon M, Allred EN, Bose C, O'Shea TM, Van Marter LJ, Ehrenkranz RA, Leviton A, ELGAN Study Investigators

Abstract

Pulmonary disease among infants of <28 weeks' gestation (extremely low gestational age newborns) often has the following pattern: the infant starts out with little need for supplemental oxygen and ventilatory support in the first postnatal week but then has pulmonary deterioration in the second postnatal week, with an increased need for supplemental oxygen and respiratory support. We evaluated the antecedents and correlates of patterns of early lung disease, with particular emphasis on pulmonary deterioration, in a large cohort study (the Extremely Low Gestational Age Newborn [ELGAN] study). We examined data collected prospectively on 1340 infants born between 2002 and 2004 at 23 to 27 completed weeks of gestation and who survived to 14 days. Pulmonary deterioration was defined as receipt of fraction of inspired oxygen < 0.23 on any day between days 3 and 7 and receipt of fraction of inspired oxygen > or = 0.25 on day 14. One fifth (20%) of the infants had consistently low fraction of inspired oxygen, approximately two fifths (38%) had pulmonary deterioration, and the remaining approximately two fifths (43%) had consistently high fraction of inspired oxygen (early and persistent lung dysfunction). Compared with infants who had consistently low fraction of inspired oxygen, infants who experienced pulmonary deterioration had lower gestational ages and lower birth weights, had higher scores for neonatal acute physiology, and received more intensive modes of respiratory support. Gender, multifetal pregnancy, cesarean delivery, antenatal steroids, chorioamnionitis, and funisitis were not associated with pulmonary deterioration. The incidence of chronic lung disease, defined as oxygen therapy at 36 weeks' postmenstrual age, was 17% in the consistently low fraction of inspired oxygen group, 51% in the pulmonary deterioration group, and 67% in the early and persistent pulmonary dysfunction group. The incidence of death in these 3 groups before 36 weeks' postmenstrual age was 1%, 3%, and 5%, respectively. Nearly 40% of extremely low gestational age newborns experience pulmonary deterioration in the first 2 postnatal weeks, and half of these infants develop chronic lung disease. Indicators of developmental immaturity and illness severity were associated with both pulmonary deterioration and chronic lung disease. Studying the antecedents of pulmonary deterioration might provide new insights about chronic lung disease pathogenesis.

MeSH Terms
Disease Progression Female Gestational Age Humans Infant, Newborn Infant, Premature Infant, Premature, Diseases/epidemiology Lung Diseases/epidemiology Male Multivariate Analysis Oxygen Inhalation Therapy Respiration, Artificial
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Laughon Matthew
Division of Neonatal-Perinatal Medicine, University of North Carolina, Chapel Hill, NC 27599-7596, USA. [email protected]
Allred Elizabeth N
Bose Carl
O'Shea T Michael
Van Marter Linda J
Ehrenkranz Richard A
Leviton Alan
ELGAN Study Investigators
Investigators
18 investigators, click to expand
Dammann Olaf
Shah Bhavesh L
Martin Camilia
Insoft Robert
Kuban Karl
Bednarek Francis
Fiascone John
Ehrenkranz Richard
O'Shea T Michael
Engelke Stephen C
Bose Carl
Poortenga Mariel
Beaumont Ed
Paneth Nigel
Schreiber Michael D
Batton Daniel
Pavlov Greg
Hirtz Deborah
References (24)
24 references, click to expand
  1. Reference weights for placentas delivered before the 28th week of gestation.
    Placenta. 2007 Oct;28(10):987-90 PMID: 17573110
  2. Clinical characteristics of chronic lung disease without preceding respiratory distress syndrome in preterm infants.
    Pediatr Int. 2005 Feb;47(1):72-9 PMID: 15693871
  3. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies.
    J Pediatr. 1996 May;128(5 Pt 1):601-7 PMID: 8627430
  4. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association.
    Pediatrics. 1999 Dec;104(6):1345-50 PMID: 10585987
  5. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis.
    Arch Dis Child Fetal Neonatal Ed. 2003 Nov;88(6):F464-6 PMID: 14602691
  6. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.
    J Pediatr. 1995 Apr;126(4):605-10 PMID: 7699543
  7. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
    Pediatrics. 2004 Sep;114(3):651-7 PMID: 15342835
  8. Atypical chronic lung disease patterns in neonates.
    Pediatrics. 1999 Apr;103(4 Pt 1):759-65 PMID: 10103299
  9. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants.
    J Pediatr. 2002 Feb;140(2):171-6 PMID: 11865267
  10. The epidemiology of atypical chronic lung disease in extremely low birth weight infants.
    J Perinatol. 2008 Feb;28(2):141-8 PMID: 18059466
  11. Contribution of inflammation to lung injury and development.
    Arch Dis Child Fetal Neonatal Ed. 2006 Mar;91(2):F132-5 PMID: 16492951
  12. SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores.
    J Pediatr. 2001 Jan;138(1):92-100 PMID: 11148519
  13. Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003.
    Pediatrics. 2008 Jan;121(1):73-81 PMID: 18166559
  14. Risk factors for the different types of chronic lung diseases of prematurity according to the preceding respiratory distress syndrome.
    Pediatr Int. 2005 Aug;47(4):417-23 PMID: 16091080
  15. Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week.
    Pediatrics. 2007 Feb;119(2):273-80 PMID: 17272616
  16. Dysfunction of pulmonary surfactant in chronically ventilated premature infants.
    Pediatr Res. 2004 Dec;56(6):918-26 PMID: 15496605
  17. Pulmonary Ureaplasma urealyticum is associated with the development of acute lung inflammation and chronic lung disease in preterm infants.
    Pediatr Res. 2004 Jan;55(1):61-8 PMID: 14605250
  18. Detection of bacteria in placental tissues obtained from extremely low gestational age neonates.
    Am J Obstet Gynecol. 2008 Jan;198(1):110.e1-7 PMID: 18166321
  19. Adrenocortical function and dysfunction in the fetus and neonate.
    Semin Neonatol. 2004 Feb;9(1):13-21 PMID: 15013472
  20. Characterization of chorioamnionitis in 2nd-trimester C-section placentas and correlation with microorganism recovery from subamniotic tissues.
    Pediatr Dev Pathol. 2008 Jan-Feb;11(1):15-22 PMID: 18237241
  21. The wealth of information conveyed by gestational age.
    J Pediatr. 2005 Jan;146(1):123-7 PMID: 15644836
  22. Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome.
    Pediatr Res. 2002 Dec;52(6):973-8 PMID: 12438678
  23. The Alabama Preterm Birth Study: intrauterine infection and placental histologic findings in preterm births of males and females less than 32 weeks.
    Am J Obstet Gynecol. 2006 Dec;195(6):1533-7 PMID: 16796981
  24. Atypical chronic lung disease in preterm infants.
    J Perinat Med. 2004;32(2):162-7 PMID: 15085893
Article Info
Journal
Pediatrics
Abbr.
Pediatrics
ISSN
1098-4275
Published
2009-04-00
Pages
1124-31
Language
English
Region
United States
NLM ID
0376422
PMCID
PMC2852187
Subset
IM
Grants
NINDS NIH HHS · U01 NS040069 · United States
NINDS NIH HHS · U01 NS040069-04 · United States
NINDS NIH HHS · 5U01NS040069-04 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]